OrthoIndy's Dr. Jack Farr implants state's 1st NUsurface implant: 4 key points

Written by Megan Wood | June 27, 2017 | Print  |

Jack Farr, MD, of Indianapolis-based OrthoIndy, performed the state's first meniscus replacement with Active Implants' NUsurface Meniscus Implant.

Here are four key points:


1. OrthoIndy is participating in the VENUS clinical trial, which involves patients with knee pain following meniscus cartilage loss.


2. The trial is testing the safety and efficacy of the investigational NUsurface compared to non-surgical standard of care.


3. Surgeons insert the implant into the knee joint via a small incision. Following surgery, patients have a six-week rehabilitation period.


4. Surgeons have used the NUsurface in Europe since 2008 and in Israel since 2011.


More articles on devices:
Conventus Orthopaedics names new CEO — 4 things to know
Mazor Robotics, Stryker, K2M & more: 19 device company key notes
Vertebral compression fracture devices market to reach $1.1M by 2022: 5 insights


© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months